MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 09.03.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITAL |
Anteile |
32.5 K |
Marktkapitalisierung |
$ 84.7 K |
EBITDA (LTM) |
$ -19.2 M |
P/E (LTM) |
-7.79 |
P/S (LTM) |
0.05 |
EPS (LTM) |
-0.34 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Biomerica
BMRA
|
$ 2.13 | -2.74 % | $ 4.89 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 25.75 | 3.0 % | $ 715 M | Nasdaq Global Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Quest Diagnostics Incorporated
DGX
|
$ 195.6 | 0.17 % | $ 21.7 B | NYSE,SPB | USA |
 |
DexCom
DXCM
|
$ 65.94 | -1.51 % | $ 25.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Brainsway Ltd.
BWAY
|
$ 13.71 | 0.37 % | $ 99.4 M | Nasdaq Global Select Market | Israel |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Fulgent Genetics
FLGT
|
$ 16.33 | 5.29 % | $ 494 M | Nasdaq Global Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Exact Sciences Corporation
EXAS
|
$ 104.91 | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.71 | 0.73 % | $ 7.5 M | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 123.79 | -0.43 % | $ 19.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 158.0 | 2.86 % | $ 7.83 B | NYSE,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 166.96 | 0.52 % | $ 28.7 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 75.73 | -0.92 % | $ 5.11 B | Nasdaq Global Select Market,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
IDEXX Laboratories
IDXX
|
$ 578.51 | 0.22 % | $ 46.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.46 | 26.96 % | $ 1.86 M | Nasdaq Capital Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 456.93 | 0.98 % | $ 13.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Agilent Technologies
A
|
$ 112.02 | 0.65 % | $ 34.1 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 100.35 | 0.65 % | $ 8.28 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
DarioHealth Corp.
DRIO
|
$ 7.5 | -6.13 % | $ 29.9 M | Nasdaq Capital Market | Israel |
 |
Guardant Health
GH
|
$ 84.9 | -0.33 % | $ 10.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.66 | 1.75 % | $ 432 M | Nasdaq Global Select Market,SPB | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
NeoGenomics
NEO
|
$ 8.1 | 1.76 % | $ 1.04 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.51 | 1.1 % | $ 392 M | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 239.07 | 2.87 % | $ 25.5 B | NYSE,SPB |  Schweiz |
 |
Natera
NTRA
|
$ 200.09 | 2.46 % | $ 19.7 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 17.56 | 2.39 % | $ 936 M | Nasdaq Global Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 3.48 | 0.87 % | $ 1.87 M | Nasdaq Global Select Market | USA |
 |
OPKO Health
OPK
|
$ 1.15 | 2.68 % | $ 798 M | Nasdaq Global Select Market | USA |
 |
Celcuity
CELC
|
$ 106.75 | 0.67 % | $ 4.21 B | Nasdaq Global Select Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 264.42 | 0.54 % | $ 22 B | NYSE,SPB | USA |
 |
Personalis
PSNL
|
$ 7.61 | 4.82 % | $ 451 M | Nasdaq Global Select Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |